🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Lori J. Goldstein

Fox Chase Cancer Center

ORCID: 0000-0002-6542-3421
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial”.

Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet Oncology(2023)10.1016/s1470-2045(22)00739-2
N/A
2.0DataRank · unranked
102 citations

Priyanka Sharma, William E. Barlow, Julie R. Gralow, Shannon L. Puhalla, Carey K. Anders +16 more

Results of a phase II randomized trial of cisplatin +/- veliparib in metastatic triple-negative breast cancer (TNBC) and/or germline BRCA-associated breast cancer (SWOG S1416).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1001
N/A
0.587DataRank · unranked
49 citations

Eve T. Rodler, William E. Barlow, Julie R. Gralow, Shannon Leigh Huggins-Puhalla, Carey K. Anders +15 more

Computational pathology improves risk stratification of a multi-gene assay for early stage ER+ breast cancer

npj Breast Cancer(2023)10.1038/s41523-023-00545-y
N/A
0.510DataRank · unranked
29 citations

Haojia Li, Andrew Janowczyk, Paula Toro, Germán Corredor, Jon Whitney +16 more

Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae314
N/A
0.443DataRank · unranked
10 citations

William E. Barlow, Julie R. Gralow, Funda Meric‐Bernstam, Kathy S. Albain, Daniel F. Hayes +19 more

Assessing association of heavy metal levels in urine and sera with neurotoxicity in breast cancer(BC) patients undergoing adjuvant/neoadjuvant chemotherapy.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e12510
N/A
0.144DataRank · unranked
1 citations

Eric A. Ross, James E. Klaunig, Tanu Singh, Rosanna Veggeberg, Katherine Alpaugh +2 more

Prospective Comparison of Geriatric Assessment and Provider’s Assessment of Older Adults With Metastatic Breast Cancer in the Community

The Oncologist(2022)10.1093/oncolo/oyab032
N/A
0DataRank · unranked
2 citations

Caitlin R. Meeker, Bianca Lewis, Elizabeth A. Handorf, Kelly Filchner, Ramya Varadarajan +11 more

Collagen fiber orientation disorder from H&E images is prognostic for early stage breast cancer: clinical trial validation

npj Breast Cancer(2021)10.1038/s41523-021-00310-z
N/A
0DataRank · unranked
55 citations

Kaustav Bera, Paula Toro, Pingfu Fu, Zelin Zhang, Cheng Lu +9 more

p53 Expression in Node-Positive Breast Cancer Patients: Results from the Cancer and Leukemia Group B 9344 Trial (159905)

UNC Libraries(2020)10.17615/n42e-6c96
N/A
0DataRank · unranked
0 citations

Lynn G. Dressler, Donald A. Berry, Lori J. Goldstein, Gloria Broadwater, Susan M. Edgerton +12 more

Race and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Positive Breast Cancer in the Randomized RxPONDER Trial

UNC Libraries(2025)10.17615/dgtt-ap31
N/A
0DataRank · unranked
0 citations

Julie R. Gralow, Edith Perez, Kevin Kalinsky, Gabriel N. Hortobágyi, Nancy U. Lin +19 more